Adjuvant treatment with aspirin seems to influence the risk of recurrence in patients with colorectal cancer, according to emerging data. Furthermore, Axel Grothey, MD, notes, treatment with aspirin even affects the number of polyps that manifest in patients with familial adenomatous polyposis.

For more from this conversation, visit http://www.onclive.com/peerexchange/...